Anatomy & Physiology Study Guide
33

Development, Pregnancy, and Inheritance

Chapter 33Reproduction and Development3 h4 sections, outcomes 1-18Week 25

Slide deck, 22 slidesFlashcards, 82Practice questions, 53 in the bank

33.1

Fertilization, Cleavage, and Implantation

0.5 hWednesday, May 5, Week 25

Outcomes

  1. 1Describe capacitation and the acrosome and cortical reactions, and state how each prevents or enables fertilization.
  2. 2Describe the week-1 sequence from zygote through cleavage, morula and blastocyst, with approximate days.
  3. 3Explain how implantation occurs and name the layers of the trophoblast and the decidual response.

Outline

  1. A

    Fertilization

    1. Fertilization usually occurs in the ampulla within about 12-24 h of ovulation; sperm remain viable for about 3-5 days in the tract spot-check.
    2. Capacitation: in the female tract, sperm lose cholesterol and seminal coating proteins, and gain hyperactivated motility and membrane fusion competence (about 6-7 h spot-check); requires Ca2+ and bicarbonate.
    3. Sperm penetrate the corona radiata (hyaluronidase) and bind ZP3 on the zona pellucida; the acrosome reaction releases acrosin and other enzymes that digest a path through the zona.
    4. Sperm-egg membrane fusion (Izumo1 on sperm, Juno on the egg spot-check) triggers a Ca2+ wave, resuming meiosis II.
    5. Cortical reaction: cortical granules release enzymes that modify ZP2 and ZP3, the block to polyspermy (the fast electrical block is minor in humans); polyspermy causes triploidy and failure.
  2. B

    Cleavage and blastocyst

    1. Zygote (day 0) has two pronuclei; cleavage is rapid mitosis without growth giving smaller blastomeres; the 2-cell stage is about 30 h, the 4-cell about 40 h spot-check.
    2. Morula (16 cells, day 3-4); compaction forms tight junctions; blastocyst forms days 4-5 with inner cell mass (embryoblast), trophoblast and blastocoel.
    3. The blastocyst hatches from the zona pellucida by about day 5-6 and attaches to the endometrium; in vitro fertilization culture exploits this timeline.
  3. C

    Implantation

    1. Begins about day 6-7 on the posterior superior uterine wall; trophoblast differentiates to cytotrophoblast (proliferating, mononuclear) and syncytiotrophoblast (invasive, multinucleated, makes hCG).
    2. The decidual reaction transforms stromal cells into glycogen- and lipid-rich decidual cells, limiting trophoblast invasion.
    3. hCG appears in maternal blood about 8-10 days after ovulation spot-check and maintains the corpus luteum; home pregnancy tests detect urine hCG.
    4. Ectopic implantation: tubal (most), cervical or abdominal; placenta previa if implanted over the internal os; placenta accreta if the decidua is deficient.

Lab

  • Draw days 0-7 from zygote to implanting blastocyst with the location in the tract on each day.
33.2

Gastrulation, Germ Layers, Organogenesis, and the Placenta

1 hThursday, May 6, Week 25

Outcomes

  1. 4Describe the week-2 events: bilaminar disc, amniotic cavity, yolk sac, extraembryonic mesoderm and the chorionic cavity.
  2. 5Explain gastrulation, including the primitive streak, and name the major derivatives of ectoderm, mesoderm and endoderm.
  3. 6Describe neurulation and the fate of the neural tube, neural crest and somites, and relate neural tube defects to folate.
  4. 7Describe the folding of the embryo and the key organogenesis milestones of weeks 4-8, including the critical period for teratogens.
  5. 8Describe the structure of the mature placenta: chorionic villi, intervillous space, decidua basalis and the layers of the placental barrier.
  6. 9Name the placental hormones and state the source, time course and role of hCG, hPL, progesterone and estrogens.

Outline

  1. A

    Weeks 2-3: bilaminar and trilaminar disc

    1. Embryoblast splits into epiblast (with amniotic cavity) and hypoblast (with primary then secondary yolk sac); extraembryonic mesoderm forms the chorionic cavity (extraembryonic coelom) and connecting stalk.
    2. Lacunar stage: syncytiotrophoblast lacunae merge with maternal sinusoids; primary, secondary, and tertiary villi (with fetal capillaries) develop by about day 21.
    3. Gastrulation (week 3): the primitive streak, node and groove appear on the epiblast; epiblast cells migrate to displace hypoblast (definitive endoderm), form intraembryonic mesoderm and the rest becomes ectoderm; the notochord forms from the node.
    4. Sacrococcygeal teratoma arises from persistent primitive streak remnants; Cranial structures such as the buccopharyngeal and cloacal membranes lack mesoderm.
  2. B

    Germ layers, neurulation and folding

    1. Ectoderm: CNS and PNS (neural tube, crest), epidermis, hair, nails, glands of the skin, lens, inner ear, enamel.
    2. Mesoderm: paraxial (somites: vertebrae, skeletal muscle, dermis), intermediate (kidney, gonads), lateral plate (heart, vessels, serosa, limb connective tissue), notochord inducing the neural plate.
    3. Endoderm: lining of the gut tube and its derivatives (liver, pancreas, respiratory epithelium), thyroid, parathyroids, thymus epithelium, bladder lining.
    4. Neurulation: neural plate, groove and folds fuse starting mid-cervical, closing the anterior neuropore about day 25 and the posterior neuropore about day 27-28 spot-check; failure causes spina bifida or anencephaly, reduced by periconceptional folic acid (about 400 micrograms per day spot-check).
    5. Lateral, cephalocaudal folding in week 4 makes a tube; the heart begins to beat about day 22-23 spot-check; limb buds appear about week 4-5.
    6. Weeks 3-8 are the embryonic period of maximal teratogen susceptibility (organogenesis); examples: thalidomide, isotretinoin, valproate, alcohol (fetal alcohol spectrum), rubella and other TORCH infections.
  3. C

    Placenta structure and circulation

    1. Fetal part: chorion frondosum with villi; maternal part: decidua basalis; intervillous space is filled with maternal blood from spiral arteries at about 10-15 mL/s spot-check; the placenta is discoid and about 500 g at term spot-check.
    2. Barrier layers in term villi: syncytiotrophoblast, thin cytotrophoblast (mostly lost), trophoblast basement membrane, villous stroma, fetal capillary endothelium.
    3. Umbilical cord: two arteries (deoxygenated blood to placenta) and one vein (oxygenated), in Wharton jelly; single umbilical artery is associated with other anomalies.
    4. Exchange: O2 and CO2 by diffusion; fetal hemoglobin high affinity and the double Bohr effect aid O2 transfer; maternal IgG crosses by receptor-mediated transcytosis; glucose by facilitated diffusion (GLUT1); large molecules and heparin do not cross.
    5. Placental pathology: previa (painless bleeding), abruption (painful bleeding), accreta spectrum (retained placenta, hemorrhage).
  4. D

    Placental hormones

    1. hCG: syncytiotrophoblast, alpha-subunit shared with LH, FSH, TSH, beta-subunit unique; doubles about every 48 h early, peaks weeks 8-10, declines to a plateau spot-check; keeps the corpus luteum making progesterone for about 7-10 weeks (luteoplacental shift).
    2. Progesterone: corpus luteum then placenta (from about week 8-10): sustains the decidua, quiets myometrium, suppresses maternal immune response, increases ventilatory drive.
    3. Estrogens: estriol is the main placental estrogen and requires the fetal adrenal DHEA-S and fetal liver (fetoplacental unit); promotes uterine growth, breast duct growth, and oxytocin receptors.
    4. hPL (human placental lactogen): rises with placental mass, causes maternal insulin resistance, lipolysis and glucose sparing for the fetus; other signals include relaxin and CRH, that set the timing of labor.

Lab

  • Draw cross sections of a day-14 bilaminar disc and a day-18 trilaminar disc, labeling the primitive streak and the layers.
  • Histology Guide MH-175 and R&P plates 95-96: find chorionic villi, syncytiotrophoblast, fetal capillaries and the intervillous space.
  • Histology Guide MHS-241: identify the umbilical arteries and vein in Wharton jelly.
  • Plot hCG, progesterone, estrogens and hPL across 40 weeks, labeling the luteoplacental shift.
33.3

Maternal Physiology of Pregnancy, Parturition, Lactation, and Neonatal Adaptation

1 hThursday, May 6, Week 25

Outcomes

  1. 10Describe maternal cardiovascular, respiratory and renal adaptations to pregnancy, giving direction and approximate magnitude.
  2. 11Explain the positive-feedback mechanism of parturition and the roles of oxytocin, prostaglandins, estrogen and progesterone.
  3. 12Name the three stages of labor and their events.
  4. 13Trace the hormonal control of lactation, including prolactin and the milk ejection reflex.
  5. 14Describe the cardiovascular and respiratory transitions at birth and the closure of the fetal shunts.

Outline

  1. A

    Maternal adaptation

    1. Cardiovascular: plasma volume up about 40-50% and blood volume up about 30-40%; red cell mass up about 20-30% so physiologic anemia develops; cardiac output up about 30-50% (peaking weeks 28-32), heart rate up about 10-20 beats/min, mean arterial pressure and SVR fall about 10 mm Hg by mid-gestation spot-check.
    2. Supine hypotension: the uterus compresses the IVC; the left lateral position relieves it.
    3. Respiratory: progesterone drives minute ventilation up about 30-50% by tidal volume; PaCO2 falls to about 30 mm Hg (respiratory alkalosis with renal compensation); FRC falls about 20%; oxygen consumption up about 20% spot-check.
    4. Renal: GFR and renal plasma flow up about 50% by the first trimester; creatinine falls to about 0.5-0.6 mg/dL; ureters dilate (right more); glucosuria is common.
    5. Other: hypercoagulable state (fibrinogen up), weight gain about 11-16 kg for normal BMI spot-check, gestational diabetes from hPL insulin resistance, preeclampsia (new hypertension after 20 weeks with proteinuria or organ dysfunction).
  2. B

    Parturition

    1. Late gestation: the progesterone-to-estrogen ratio shifts functionally, the myometrium acquires oxytocin receptors and gap junctions; cervical ripening is driven by prostaglandins and collagen remodeling.
    2. Positive feedback (Ferguson reflex): fetal head stretches the cervix, afferent signals reach the hypothalamus, oxytocin from the posterior pituitary strengthens contractions and further stretch; prostaglandins amplify.
    3. Stage 1: onset of regular contractions to full dilation (10 cm), latent then active; stage 2: full dilation to delivery of the infant (pushing); stage 3: delivery of the placenta, within about 30 min spot-check.
    4. Oxytocin or uterotonics (misoprostol, methylergonovine, carboprost) control postpartum hemorrhage; tocolytics delay preterm labor.
  3. C

    Lactation

    1. Pregnancy: estrogen grows ducts, progesterone grows lobuloalveoli, hPL, prolactin and insulin also contribute; milk synthesis is inhibited until placental steroids fall at delivery.
    2. After delivery: prolactin from anterior pituitary lactotrophs (inhibited by hypothalamic dopamine) stimulates milk synthesis; suckling reduces dopamine and raises prolactin.
    3. Milk ejection (let-down): nipple afferents act on the hypothalamus, oxytocin acts on myoepithelial cells around alveoli, the milk is released; psychological stress inhibits it.
    4. Colostrum in the first days is rich in IgA, protein and low in fat; mature milk by about 2 weeks; high prolactin suppresses GnRH and gives lactational amenorrhea (about 98% effective for 6 months if exclusive) spot-check.
  4. D

    Neonatal transition

    1. First breath and lung inflation, with absorption of fetal lung fluid and surfactant (type II cells, mature at about 34-36 weeks), drop pulmonary vascular resistance and increase pulmonary flow; Apgar score at 1 and 5 min assesses status.
    2. Clamping of the cord removes the low-resistance placental circuit and raises systemic resistance; left atrial pressure exceeds right, and the foramen ovale closes functionally.
    3. Higher PO2 and falling prostaglandin E2 constrict the ductus arteriosus (functional closure in hours to days; ligamentum arteriosum later; NSAIDs, indomethacin close a PDA); the ductus venosus becomes the ligamentum venosum, the umbilical vein the ligamentum teres, the umbilical arteries the medial umbilical ligaments (see ch. 25).
    4. Neonatal respiratory distress syndrome follows surfactant deficiency in prematurity; antenatal corticosteroids speed lung maturation; thermoregulation depends on brown fat.

Lab

  • Histology Guide MH-174b and R&P plates 98-99: compare resting with lactating breast by lobule size, alveolar lumina and secretory vacuoles.
  • Draw the oxytocin positive-feedback loop of labor and the prolactin and oxytocin reflexes of suckling.
  • Make a before-and-after table of the neonatal circulation: pressures, shunts and resistances at first breath.
33.4

Patterns of Inheritance

0.5 hThursday, May 6, Week 25

Outcomes

  1. 15Distinguish autosomal dominant, autosomal recessive, X-linked recessive and X-linked dominant inheritance from pedigree features.
  2. 16Calculate offspring probabilities using Punnett squares and carrier probabilities for monohybrid and sex-linked crosses.
  3. 17Explain non-Mendelian patterns: mitochondrial inheritance, genomic imprinting, incomplete penetrance, codominance and trinucleotide repeat anticipation.
  4. 18Relate nondisjunction to common aneuploidies and explain mosaicism.

Outline

  1. A

    Mendelian patterns and pedigrees

    1. Autosomal dominant: affected in every generation, vertical transmission, either sex, about 50% of children of an affected heterozygote (Huntington, Marfan, familial hypercholesterolemia).
    2. Autosomal recessive: often skips generations, both sexes, unaffected parents are carriers (25% affected, 50% carrier); consanguinity raises risk (cystic fibrosis, sickle cell disease, Tay-Sachs).
    3. X-linked recessive: mostly males, no male-to-male transmission, carrier mothers pass to about 50% of sons and make about 50% of daughters carriers (hemophilia A, Duchenne, G6PD deficiency); affected fathers have all carrier daughters.
    4. X-linked dominant: both sexes, affected fathers pass it to all daughters and no sons (vitamin D resistant rickets, fragile X also has X-linked features).
    5. Pedigree symbols: squares male, circles female, filled affected, diagonal line deceased, double line consanguinity, proband arrow.
  2. B

    Genotype, phenotype and probability

    1. Alleles, homozygous and heterozygous genotypes; dominance, incomplete dominance (intermediate) and codominance (both expressed, ABO and AB blood type).
    2. Hardy-Weinberg: p2 + 2pq + q2 = 1 gives carrier frequency of 2pq from disease prevalence q2 (for example CF prevalence about 1 in 2500 gives carrier about 1 in 25) spot-check.
    3. Penetrance is the fraction of genotype carriers with a phenotype; expressivity is the variation in severity; variable expressivity occurs in neurofibromatosis 1.
    4. Independent assortment for unlinked loci; linked loci recombine less often; Bayesian adjustment applies when healthy relatives lower carrier probability.
  3. C

    Non-Mendelian inheritance

    1. Mitochondrial: maternal inheritance, all children of an affected mother can be affected, none from an affected father; heteroplasmy gives variable severity (Leber hereditary optic neuropathy, MELAS).
    2. Imprinting: expression depends on parent of origin; Prader-Willi (paternal 15q11-13 loss), Angelman (maternal loss, UBE3A).
    3. Trinucleotide repeat expansion causes anticipation: Huntington (CAG, paternal anticipation), fragile X (CGG, maternal expansion).
    4. Sex determination: XX female, XY male; X-inactivation (Lyon) randomly silences one X in each female cell, giving mosaic expression in carriers.
  4. D

    Chromosomal abnormalities

    1. Nondisjunction in meiosis I or II gives trisomy 21 (Down, risk rises with maternal age, usually maternal meiosis I), 18, 13; sex aneuploidy includes 45,X (Turner) and 47,XXY (Klinefelter).
    2. Mosaicism arises from postzygotic mitotic error, giving two cell lines and often milder phenotype; translocation Down syndrome (Robertsonian 14;21) carries a recurrence risk independent of age.
    3. Prenatal testing: first-trimester ultrasound (nuchal translucency), cell-free fetal DNA screening from about 10 weeks, chorionic villus sampling at 10-13 weeks, amniocentesis at 15-20 weeks spot-check.

Lab

  • Draw and classify five unlabeled pedigrees (AD, AR, XLR, XLD, mitochondrial), and justify each by the exclusion rules.
  • Work Punnett and Hardy-Weinberg problems: carrier frequency of CF, probability that the second son of a carrier mother has hemophilia.
  • Identify the aneuploidy from three sample karyotypes (47,XX,+21; 45,X; 47,XXY).

Teach-back prompts

  1. Narrate fertilization to implantation: where each event occurs, the day, and what each reaction (capacitation, acrosome, cortical) accomplishes.
  2. Explain how the placenta takes over the role of the corpus luteum and which hormone signals this to the mother.
  3. Describe the maternal cardiovascular and renal changes of pregnancy with numbers, and explain which are driven by progesterone, estrogen and volume expansion.
  4. Give a pedigree rule set so a stranger could classify any pedigree as AD, AR, XLR or mitochondrial.

Practical targets

  • Placental villi with syncytiotrophoblast and fetal capillaries (Histology Guide MH-175)
  • Placenta villus detail (R&P plates 95-96)
  • Umbilical cord, two arteries and a vein (Histology Guide MHS-241)
  • Lactating mammary gland (Histology Guide MH-174b)
  • Lactating versus resting breast (R&P plates 98-99)
  • Primitive streak stage embryo diagram (bilaminar to trilaminar disc)
  • Blastocyst with inner cell mass and trophoblast (diagram)
  • Pedigree with X-linked recessive pattern
  • Karyotype 47,XX,+21
  • Karyotype 47,XXY

Also see